Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2025-12-26 @ 1:15 AM
NCT ID:
NCT04716634
Pre Assignment Details:
The study consisted of 2 parts: Part 1 (Safety run-in) and Part 2 (Extension). Part 1 of the study with limited participants assessed dose-limiting toxicities (DLTs) and recommended Phase 2 dose (RP2D). These participants later moved to Part 2 of the study. Participant flow, baseline demographics and adverse event data were planned to be reported and analyzed for the combined Part 1 and Part 2 of study. All participants received same dose of study drugs (tislelizumab and fruquintinib).
Study:
NCT04716634
Study Brief:
Results Section:
NCT04716634